<p>* represented the comparison of actual stable wafarin dose in different genotypes for the gene polymorphisms of VKORC1 and CYP2C9*3.</p><p>** represented the actual initial warfarin dose comparison in different genotypes for the gene polymorphisms of VKORC1 and CYP2C9*3.</p
Background: The aim of this study is to assess the accuracy of warfarin dosage based on VKORC1 and C...
Excepting host genetic factors, other influences on the pharmacokinetic and pharmacodynamic behavior...
Objectives: The aim of this study was to evaluate the associations between polymorphisms of VKORC1, ...
<p>Each box indicates the values from 25° to 75° percentile (interquartile range), the white lines r...
A dosing algorithm including genetic (VKORC1 and CYP2C9 genotypes) and nongenetic factors (age, weig...
<p>Each box indicates the values from 25° to 75° percentile (interquartile range), the horizontal li...
Polymorphisms in CYP 2C9 and VKOR C1 have been shown to be associated with warfarin dose requirement...
Pētījuma mērķis. Novērtēt varfarīna farmakoģenētiska testa prognozēto devu atbilstību pacientu fakti...
Aim: Our aim was to examine the effect of CYP2C9 and VKORC1 polymorphisms on warfarin dose requireme...
with decreased S-warfarin clearance and lower mainte-nance dosage. Decreased expression of VKORC1 re...
Warfarin is used in paediatric populations, but dosing algorithms incorporating pharmacogenetic data...
There is a large variability in warfarin dosage requirements. While some variability is related to f...
It was aimed to underline the importance and explain the meaning of genetic testing in warfarin dosi...
What is known and Objectives: Testing for cytochrome P450-2C9 (CYP2C9) and vitamin K epoxide reduct...
Objectives: Warfarin is a commonly prescribed anticoagulant drug used to prevent thromboses that may...
Background: The aim of this study is to assess the accuracy of warfarin dosage based on VKORC1 and C...
Excepting host genetic factors, other influences on the pharmacokinetic and pharmacodynamic behavior...
Objectives: The aim of this study was to evaluate the associations between polymorphisms of VKORC1, ...
<p>Each box indicates the values from 25° to 75° percentile (interquartile range), the white lines r...
A dosing algorithm including genetic (VKORC1 and CYP2C9 genotypes) and nongenetic factors (age, weig...
<p>Each box indicates the values from 25° to 75° percentile (interquartile range), the horizontal li...
Polymorphisms in CYP 2C9 and VKOR C1 have been shown to be associated with warfarin dose requirement...
Pētījuma mērķis. Novērtēt varfarīna farmakoģenētiska testa prognozēto devu atbilstību pacientu fakti...
Aim: Our aim was to examine the effect of CYP2C9 and VKORC1 polymorphisms on warfarin dose requireme...
with decreased S-warfarin clearance and lower mainte-nance dosage. Decreased expression of VKORC1 re...
Warfarin is used in paediatric populations, but dosing algorithms incorporating pharmacogenetic data...
There is a large variability in warfarin dosage requirements. While some variability is related to f...
It was aimed to underline the importance and explain the meaning of genetic testing in warfarin dosi...
What is known and Objectives: Testing for cytochrome P450-2C9 (CYP2C9) and vitamin K epoxide reduct...
Objectives: Warfarin is a commonly prescribed anticoagulant drug used to prevent thromboses that may...
Background: The aim of this study is to assess the accuracy of warfarin dosage based on VKORC1 and C...
Excepting host genetic factors, other influences on the pharmacokinetic and pharmacodynamic behavior...
Objectives: The aim of this study was to evaluate the associations between polymorphisms of VKORC1, ...